您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[OIV]:2025年总结-适度饮酒与胃肠道疾病 - 发现报告

2025年总结-适度饮酒与胃肠道疾病

食品饮料2025-12-11OIVX***
AI智能总结
查看更多
2025年总结-适度饮酒与胃肠道疾病

Background: This work is part of a broader series of scientific literature reviews on the impactof vitivinicultural products on human health. It aligns with Axis 6 of the OIV Strategic Plan2025–2029, which aims to contribute to consumer safety and enhance understanding of therelationship between wine, vine, and society. The review is supported by the OIV Resolution Thepresent review focuses on the relationship between wine consumption andgastrointestinal (GI) diseases, following up on the 2024 review addressing immune-mediateddiseases and moderate wine consumption. This initiative was launched in 2023 by the expert The objective was to assess the current scientific evidence regarding the influence of alcoholicbeverages, especially wine, on the incidence and severity of GI disorders. The reviewhighlightsstudies that explore both potential benefits and risks of moderate wine Abstract: By conducting a narrative review of the scientific literature, the authors of this studysought to verify whether there were sufficient data to answer the following question: “Canwine positively or negatively influence the incidence and severity of disorders associated withgastrointestinal (GI) diseases?”. In this review, most of the studies considered tested differentalcoholic beverages (other than wine), not always reporting in the conclusions the possibledifference in the extent of symptoms. Although alcohol certainly plays a central role ininfluencing the oesophageal and gastric environment, no studies evaluating the role of alcoholas such were included, since the aim of the review was to understand whether wine can bemoderately consumedby patients with gastrointestinal diseases. The analysis of studiesselected from the main reference databases indicates that even moderate wine consumption Keywords: gastrointestinal diseases; wine; alcoholic beverages; inflammatory bowel diseaseor IBD; irritable bowel syndrome or IBS; gastroesophageal disease or GERD. Reference: Restani, P., Di Lorenzo, C., Antoce, A. O., Araujo, M., Bani, C., Mercogliano, F., Ruf,J.-C., Kosti, R. I., & Teissedre, P.-L. (2025).Moderate Wine Consumption and GastrointestinalDiseases. Nutrients, 17(10), 1608.https://doi.org/10.3390/nu17101608 Click here to access the article:https://www.mdpi.com/2072-6643/17/10/1608